Summary
Updated Aug 31, 2026
Eugene Myron Holuka is Director of CITIUS ONCOLOGY, INC. (CTOR). 5 SEC Form 4 filings on record going back to 2024, most recently on 22 December 2025.
Recent Transactions
3Every recent SEC Form 4 transaction Eugene Myron Holuka has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Eugene Myron Holuka's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- ILLUMINA, INC. - $79.85M of GRAL open-market activity in the last 12 months
- Darren M. Black - $77.56M of LFST open-market activity in the last 12 months
- Brian Guan-Chyun Liu - $74.81M of CGON open-market activity in the last 12 months
- Keith A. Meister - $74.03M of WGS open-market activity in the last 12 months
- Warren B. Kanders - $73.88M of CDRE open-market activity in the last 12 months
- Amirali Talasaz - $73.75M of GH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Eugene Myron Holuka?
Eugene Myron Holuka is a corporate insider, tracked as Director of CITIUS ONCOLOGY, INC. (CTOR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Eugene Myron Holuka last file a Form 4?
The most recent primary Form 4 on record is dated 22 December 2025, one of 5 filings going back to 2024.
Where can I see all of Eugene Myron Holuka's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Eugene Myron Holuka and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
